tirzepatide consent form for weight loss GLP-1 Informed & Risk Disclosure Kit Free Medical Weight Loss Consent

Tirzepatide (LY3298176), a dual GIP and GLP-1 receptor (GLP-1R) agonist, delivered superior glycemic control and weight loss compared with GLP-1R agonism in patients with type 2 diabetes

NICE Symptoms to watch for (because numbers arent everything) Contact your clinician if you notice new symptoms that persist for a couple of weeks, such as: Possible under-replacement (hypothyroid): fatigue, low mood, feeling cold, constipation, dry skin, slower heart rate Possible over-replacement (hyperthyroid): palpitations, tremor, anxiety, sweating, heat intolerance, diarrhoea, trouble sleeping These symptoms can overlap with diet changes and early Mounjaro side effects, so blood tests help clarify whats going on

These options arent mutually exclusive

Offer resources for readers to learn more about safe and effective weight management strategies

Clinically Proven Mechanism: How Tirzepatide Promotes Weight Loss At CT Medical Body Management & Beyond, we understand that managing body mass can be a challenging journey

Yes, though you might need to modify your routine during peak fatigue periods